Xu Y - Search Results

1

mRNA-Based Therapeutics in Cancer Treatment.

Sun H, Zhang Y, Wang G, Yang W, Xu Y. Sun H, et al. Among authors: xu y. Pharmaceutics. 2023 Feb 13;15(2):622. doi: 10.3390/pharmaceutics15020622. Pharmaceutics. 2023. PMID: 36839944 Free PMC article. Review.

2

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

Xu Y, Yang W, Shi J, Zetter BR. Xu Y, et al. J Mol Cell Biol. 2016 Jun;8(3):282-5. doi: 10.1093/jmcb/mjw018. Epub 2016 Mar 29. J Mol Cell Biol. 2016. PMID: 27025967 Free PMC article. No abstract available.

3

Prohibitin regulates mTOR pathway via interaction with FKBP8.

Zhang J, Yin Y, Wang J, Zhang J, Liu H, Feng W, Yang W, Zetter B, Xu Y. Zhang J, et al. Among authors: xu y. Front Med. 2021 Jun;15(3):448-459. doi: 10.1007/s11684-020-0805-6. Epub 2020 Dec 1. Front Med. 2021. PMID: 33259040

4

Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation.

Xia J, Zhang J, Wang L, Liu H, Wang J, Liu J, Liu Z, Zhu Y, Xu Y, Yang W, Yu Y. Xia J, et al. Among authors: xu y. Cell Death Dis. 2021 Sep 4;12(9):833. doi: 10.1038/s41419-021-04126-4. Cell Death Dis. 2021. PMID: 34482382 Free PMC article.

5

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.

Zhang J, Li Y, Liu H, Zhang J, Wang J, Xia J, Zhang Y, Yu X, Ma J, Huang M, Wang J, Wang L, Li Q, Cui R, Yang W, Xu Y, Feng W. Zhang J, et al. Among authors: xu y. J Exp Clin Cancer Res. 2022 Jan 15;41(1):24. doi: 10.1186/s13046-022-02242-3. J Exp Clin Cancer Res. 2022. PMID: 35033172 Free PMC article.

6

Structural basis for the activity and regulation of human α-ketoglutarate dehydrogenase revealed by Cryo-EM.

Zhong Y, Gao Y, Zhou D, Ma X, Chen H, Xu Y, Yang W, Yu X. Zhong Y, et al. Among authors: xu y. Biochem Biophys Res Commun. 2022 Apr 30;602:120-126. doi: 10.1016/j.bbrc.2022.02.093. Epub 2022 Mar 2. Biochem Biophys Res Commun. 2022. PMID: 35272141

7

Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer.

Mao C, Chen J, Zou T, Zhou Y, Liu J, Li X, Li X, Li M, Pan P, Zhuo W, Gao Y, Hu S, Xiao D, Wu L, Wang Z, Xu H, Yang W, Xu Y, Xiao H, Hanada K, Zhang W, Zhou H, Yin J, Liu Z. Mao C, et al. Among authors: xu h, xu y. Acta Pharm Sin B. 2022 Mar;12(3):1514-1522. doi: 10.1016/j.apsb.2021.10.007. Epub 2021 Oct 16. Acta Pharm Sin B. 2022. PMID: 35530157 Free PMC article.

8

Chemically modified in-vitro-transcribed mRNA encoding thrombopoietin stimulates thrombopoiesis in mice.

Zhang Y, Xi X, Yu H, Yang L, Lin J, Yang W, Liu J, Fan X, Xu Y. Zhang Y, et al. Among authors: xu y. Mol Ther Nucleic Acids. 2022 Aug 13;29:657-671. doi: 10.1016/j.omtn.2022.08.017. eCollection 2022 Sep 13. Mol Ther Nucleic Acids. 2022. PMID: 36090760 Free PMC article.

9

Lipid Nanoparticle Delivery of Chemically Modified NGF^R100W mRNA Alleviates Peripheral Neuropathy.

Yu X, Yang Z, Zhang Y, Xia J, Zhang J, Han Q, Yu H, Wu C, Xu Y, Xu W, Yang W. Yu X, et al. Among authors: xu w, xu y. Adv Healthc Mater. 2023 Jan;12(3):e2202127. doi: 10.1002/adhm.202202127. Epub 2022 Nov 18. Adv Healthc Mater. 2023. PMID: 36325948

10

An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease.

Xia J, Hou Y, Cai A, Xu Y, Yang W, Huang M, Mou S. Xia J, et al. Among authors: xu y. Front Immunol. 2023 Feb 17;14:1129524. doi: 10.3389/fimmu.2023.1129524. eCollection 2023. Front Immunol. 2023. PMID: 36875100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,377 results

Search Page